Pulmonary Veno-Occlusive Disease-Reference-Cited by-同舟云学术

Pulmonary Veno-Occlusive Disease

Published:2008-07 Issue:4 Volume:87 Page:220-233
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Montani David,Achouh Lara,Dorfmüller Peter,Le Pavec Jérôme,Sztrymf Benjamin,Tchérakian Colas,Rabiller Anne,Haque Rehan,Sitbon Olivier,Jaïs Xavier,Dartevelle Philippe,Maître Sophie,Capron Frédérique,Musset Dominique,Simonneau Gérald,Humbert Marc

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference50 articles.

1. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hpertension Study Group.;Abenhaim;N Engl J Med,1996

2. Pulmonary capillary hemangiomatosis associated with primary pulmonary hypertension: report of 2 new cases and review of 35 cases from the literature.;Almagro;Medicine (Baltimore),2002

3. ATS statement: guidelines for the six-minute walk test.;Am J Respir Crit Care Med,2002

4. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group.;Barst;N Engl J Med,1996

5. Primary pulmonary hypertension: a histopathologic study of 80 cases.;Bjornsson;Mayo Clin Proc,1985

Cited by 301 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology of supplemental oxygen in patients with pulmonary hypertension;Respirology;2024-08-29

2. Treatment algorithm for pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

3. Rare clinical case: pulmonary venoocclusive disease;PULMONOLOGIYA;2024-07-10

4. Reversal of pulmonary veno-occlusive disease phenotypes by inhibition of the integrated stress response;Nature Cardiovascular Research;2024-07-09

5. Omega‐3 polyunsaturated fatty acids and pulmonary arterial hypertension: Insights and perspectives;European Journal of Clinical Investigation;2024-06-28